[2]   Nierth-Simpson EN, Martin MM, Chiang TC, et al. Humanuterine smooth muscle and leiomyoma cells differ in theirrapid 17 beta-estradiol signaling: implications forproliferation[J]. Endocrinology, 2009, 150(5): 2436-2445.

[3]   Lv JQ, Zhu XQ, Dong K, et al. Reduced expression of 14-3-3 gamma in uterine leiomyoma as identified by proteomics [J]. Fertil Steril, 2008, 90(5): 1892-1898.

[4]   金慧佩, 余方芳, 赵雅萍, 等. 不同因素对子宫肌瘤HIFU治疗疗效影响的初步分析[J]. 温州医学院学报, 2013, 43(6): 379-382.

[5]   Hoekstra AV, Sefton EC, Berry E, et al. Progestins activatethe AKT pathway in leiomyoma cells and promote survival [J]. J Clin Endocrinol Metab, 2009, 94(5): 1768-1774.

[6]   Bergamaschi A, Frasor J, Borgen K, et al. 14-3-3ζas apredictor of early time to recurrence and distant metastasisin hormone receptor-positive and -negative breast cancers [J]. Breast Cancer Res Treat, 2013, 137(3): 689-696.

[7]   Ravi D, Chen Y, Karia B, et al. 14-3-3σexpression effectsG2/M response to oxygen and correlates with ovarian cancer metastasis[J]. PLoS One, 2011, 6(1): e15864.

[8]   Park SG, Jung S, Ryu HH, et al. Role of 14-3-3-beta in themigration and invasion in human malignant glioma cell lineU87MG[J]. Neurol Res, 2012, 34(9): 893-900.

[9]      Kao GS, Chuang JY, Cherng CF, et al. Accumbal 14-3-3ζprotein downregulation is associated with cocaine-condi-tioned memory[J]. Neurosignals, 2011, 19(4): 175-188.